Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study

Rui Song, Gang Zeng, Jianxing Yu, Xing Meng, Xiaoyou Chen, Jing Li, Xiaoliang Xie, Xiaojuan Lian, Zhiyun Zhang, Yunlong Cao, Weidong Yin, Ronghua Jin
doi: https://doi.org/10.1101/2022.12.28.22283666

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted January 04, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study
Rui Song, Gang Zeng, Jianxing Yu, Xing Meng, Xiaoyou Chen, Jing Li, Xiaoliang Xie, Xiaojuan Lian, Zhiyun Zhang, Yunlong Cao, Weidong Yin, Ronghua Jin
medRxiv 2022.12.28.22283666; doi: https://doi.org/10.1101/2022.12.28.22283666
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area